First Trust Advisors
CDMO

First Trust Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

First Trust Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-134,196
Closed -$1.85M – 2496
2022
Q4 		$1.85M Buy
+134,196
New +$2.06M ﹤0.01% 1727
2022
Q2 		– Sell
-154,234
Closed -$3.14M – 2631
2022
Q1 		$3.14M Buy
154,234
+2,383
+2% +$48.5K ﹤0.01% 1590
2021
Q4 		$4.43M Buy
+151,851
New +$4.35M ﹤0.01% 1428

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

First Trust Advisors's CDMO Position: Q1 2023 in Review

First Trust Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2023, closing a stake of 134,196 shares — an estimated $1.85M sold.

First Trust Advisors first reported a position in CDMO in Q4 2021 and held it in 3 quarters. The position peaked at $4.43M in Q4 2021. 168 funds tracked by Wall St. Rank hold CDMO as of Q1 2023.

  • First Trust Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • First Trust Advisors sold 134,196 Avid Bioservices, Inc. Common Stock shares in Q1 2023, an estimated $1.85M.
  • First Trust Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • First Trust Advisors's Avid Bioservices, Inc. Common Stock position peaked at $4.43M in Q4 2021.
  • 168 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2023.

Based on First Trust Advisors's 13F filing for Q1 2023, filed 15 May 2023.